These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 20855563)

  • 21. Characterizing TDP-43 interaction with its RNA targets.
    Bhardwaj A; Myers MP; Buratti E; Baralle FE
    Nucleic Acids Res; 2013 May; 41(9):5062-74. PubMed ID: 23519609
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quantification of the Relative Contributions of Loss-of-function and Gain-of-function Mechanisms in TAR DNA-binding Protein 43 (TDP-43) Proteinopathies.
    Cascella R; Capitini C; Fani G; Dobson CM; Cecchi C; Chiti F
    J Biol Chem; 2016 Sep; 291(37):19437-48. PubMed ID: 27445339
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Heat Shock-induced Phosphorylation of TAR DNA-binding Protein 43 (TDP-43) by MAPK/ERK Kinase Regulates TDP-43 Function.
    Li W; Reeb AN; Lin B; Subramanian P; Fey EE; Knoverek CR; French RL; Bigio EH; Ayala YM
    J Biol Chem; 2017 Mar; 292(12):5089-5100. PubMed ID: 28167528
    [TBL] [Abstract][Full Text] [Related]  

  • 24. TDP-43 and frontotemporal dementia.
    Hu WT; Grossman M
    Curr Neurol Neurosci Rep; 2009 Sep; 9(5):353-8. PubMed ID: 19664364
    [TBL] [Abstract][Full Text] [Related]  

  • 25. RNA and Protein Interactors with TDP-43 in Human Spinal-Cord Lysates in Amyotrophic Lateral Sclerosis.
    Volkening K; Keller BA; Leystra-Lantz C; Strong MJ
    J Proteome Res; 2018 Apr; 17(4):1712-1729. PubMed ID: 29513014
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of transactive response DNA-binding protein-43 in amyotrophic lateral sclerosis and frontotemporal dementia.
    Mackenzie IR; Rademakers R
    Curr Opin Neurol; 2008 Dec; 21(6):693-700. PubMed ID: 18989115
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development of a novel high-throughput screen and identification of small-molecule inhibitors of the Gα-RGS17 protein-protein interaction using AlphaScreen.
    Mackie DI; Roman DL
    J Biomol Screen; 2011 Sep; 16(8):869-77. PubMed ID: 21680864
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Binding of HIV-1 TAR mRNA to a peptide nucleic acid oligomer and its conjugates with metal-ion-binding multidentate ligands.
    Belousoff MJ; Gasser G; Graham B; Tor Y; Spiccia L
    J Biol Inorg Chem; 2009 Feb; 14(2):287-300. PubMed ID: 19015900
    [TBL] [Abstract][Full Text] [Related]  

  • 29. TDP-43 proteinopathies: pathological identification of brain regions differentiating clinical phenotypes.
    Tan RH; Kril JJ; Fatima M; McGeachie A; McCann H; Shepherd C; Forrest SL; Affleck A; Kwok JB; Hodges JR; Kiernan MC; Halliday GM
    Brain; 2015 Oct; 138(Pt 10):3110-22. PubMed ID: 26231953
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Aggresome formation and liquid-liquid phase separation independently induce cytoplasmic aggregation of TAR DNA-binding protein 43.
    Watanabe S; Inami H; Oiwa K; Murata Y; Sakai S; Komine O; Sobue A; Iguchi Y; Katsuno M; Yamanaka K
    Cell Death Dis; 2020 Oct; 11(10):909. PubMed ID: 33097688
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Different recognition modes of G-quadruplex RNA between two ALS/FTLD-linked proteins TDP-43 and FUS.
    Ishiguro A; Katayama A; Ishihama A
    FEBS Lett; 2021 Feb; 595(3):310-323. PubMed ID: 33269497
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [A new dementia group caused by TDP-43 abnormality].
    Arai T; Hosokawa M; Hasegawa M; Akiyama H; Asada T
    Seishin Shinkeigaku Zasshi; 2011; 113(6):574-83. PubMed ID: 21815469
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Physiological functions and pathobiology of TDP-43 and FUS/TLS proteins.
    Ratti A; Buratti E
    J Neurochem; 2016 Aug; 138 Suppl 1():95-111. PubMed ID: 27015757
    [TBL] [Abstract][Full Text] [Related]  

  • 34. TAR DNA-binding protein 43 in neurodegenerative disease.
    Chen-Plotkin AS; Lee VM; Trojanowski JQ
    Nat Rev Neurol; 2010 Apr; 6(4):211-20. PubMed ID: 20234357
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development of a novel β-secretase binding assay using the AlphaScreen platform.
    Ren Z; Tam D; Xu YZ; Wone D; Yuan S; Sham HL; Cheung H; Regnstrom K; Chen X; Rudolph D; Jobling MF; Artis DR; Bova MP
    J Biomol Screen; 2013 Jul; 18(6):695-704. PubMed ID: 23543430
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of TDP-43 in the pathogenesis of ALS and FTLD.
    Baralle M; Buratti E; Baralle FE
    Biochem Soc Trans; 2013 Dec; 41(6):1536-40. PubMed ID: 24256250
    [TBL] [Abstract][Full Text] [Related]  

  • 37. TAR DNA binding protein-43 and fused in sarcoma/translocated in liposarcoma protein in two neurodegenerative diseases.
    Wang XN; Cui LY
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2012 Jun; 34(3):286-92. PubMed ID: 22776664
    [TBL] [Abstract][Full Text] [Related]  

  • 38. TDP-43 mediates degeneration in a novel Drosophila model of disease caused by mutations in VCP/p97.
    Ritson GP; Custer SK; Freibaum BD; Guinto JB; Geffel D; Moore J; Tang W; Winton MJ; Neumann M; Trojanowski JQ; Lee VM; Forman MS; Taylor JP
    J Neurosci; 2010 Jun; 30(22):7729-39. PubMed ID: 20519548
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Granulins modulate liquid-liquid phase separation and aggregation of the prion-like C-terminal domain of the neurodegeneration-associated protein TDP-43.
    Bhopatkar AA; Uversky VN; Rangachari V
    J Biol Chem; 2020 Feb; 295(8):2506-2519. PubMed ID: 31911437
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of mutant TAR DNA-binding protein 43 in amyotrophic lateral sclerosis and frontotemporal lobar degeneration.
    Janssens J; Kleinberger G; Wils H; Van Broeckhoven C
    Biochem Soc Trans; 2011 Aug; 39(4):954-9. PubMed ID: 21787329
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.